Andrew Callos, EVP, Chief Commercial Officer at CYTOKINETICS INC (CYTK), sold 17,318 shares at $32.04 ($555K) on 2025-06-05, disclosed to the SEC on 2025-06-05.
Scheduled sale ($555k) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.04 | 8,659 | $277K | 50.0% |
| 2 | $32.04 | 8,659 | $277K | 50.0% |
| Total | $32.04 avg | 17,318 | $555K | 100% |
| Filing → |
| CYTK | SELL | 2026-07-02 | $1.3M | — | Filing → |
| CYTK | SELL | 2026-06-01 | $1.1M | — | Filing → |
| CYTK | SELL | 2026-05-05 | $875K | — | Filing → |